Liver Diseases  >>  sirolimus  >>  Phase 3
Welcome,         Profile    Billing    Logout  

3 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
sirolimus / Generic mfg.
NCT00355862 / 2005-005362-36: Immunosuppression in Patients Undergoing Liver Transplantation for Hepatocellular Carcinoma

Completed
3
525
Europe
CNI, MMF, Steroids, Aza etc. (mTOR inhibitor free), Cyclosporine, Tacrolimus, Azathioprine, MMF, Prednisolone, etc, Sirolimus, Rapamune
University of Regensburg
Hepatocellular Carcinoma
04/09
05/14
PATRON07, NCT00604357: CNI-free de Novo Protocol in Patients Undergoing Liver Transplantation With Renal Impairment

Completed
3
27
Europe
anti-CD 25 mAb, Sirolimus, MMF, Rapamune, Simulect, CellCept, DecortinH
University of Regensburg
End Stage Liver Disease, Impaired Renal Function
07/11
08/12
NCT00328770: De Novo Sirolimus-based Immunosuppression After Liver Transplantation for Hepatocellular Carcinoma

Completed
2/3
70
Canada
Sirolimus, Rapamune
University of Alberta
Liver Carcinoma
03/06
03/06

Download Options